Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic cord blood cells

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic cord blood cells, covering 2020-04-02 to 2020-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury [Phase 1, Phase 2]

See pricing